Concentric Analgesics Stock

concentricanalgesics.comHealthcareFounded: 2014Funding to Date: $85.36MM

Concentric Analgesics is a biotechnology company focused on discovering and developing novel, non-opioid therapeutics for the management of acute and chronic pain.

Register for Details

For more details on financing and valuation for Concentric Analgesics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Concentric Analgesics.

Register Today

Team

Management Team

John Donovan MD
Co-Founder, President & Board Member
Mike Royal MD
Chief Medical Officer
Frank Bellizzi Jr.
Chief Executive Officer & Board Member
Thomas King
Executive Chairman & Board Member
Ryan Daws
Chief Financial Officer
Craig Husfeld Ph.D
Co-Founder, Chief Scientific Officer & Board Member

Board Members

Craig Husfeld Ph.D
Thomas King
Frank Bellizzi Jr.
John Donovan MD

Other companies like Concentric Analgesics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM